| abstract |
Provided herein are methods and compositions for treating cancers, inflammatory ndiseases, rasopathies, and fibrotic disease involving aberrant Ras superfamily signaling through nthe binding of compounds to the GTP binding domain of Ras superfamily proteins including, in ncertain cases, K-Ras and mutants thereof, and a novel method for assaying such compositions |